SPI 20

SPI 20
FoundationJuly 4, 2017 [1]
OperatorSIX Swiss Exchange
ExchangesSIX Swiss Exchange
Trading symbolSPI2C
Constituents20
TypeLarge cap
Market capCHF 1,145 billion (full, end 2017)[2]
Weighting methodMarket value-weighted, free-float-adjusted
Related indicesSMI, SPI, SPI Extra
Website[1]
ISINCH0368313778
Reuters.SPI2C
BloombergSPI2C

The SPI 20 is a capitalization-weighted stock index of large-cap companies listed on the SIX Swiss Exchange.[2]

It is made up of the same components as the Swiss Market Index, except that it does not have any cap on the maximum percentage that a component can have. It was created in 2017, after the largest SMI constituents were capped at 18%. The index was standardized at 1500 points on 30 June 1988 and the history is available back until 29 January 1988.[1]

Current constituents

As of September 20, 2021, the following 20 stocks make up the SPI 20 index.[2]

Company ICB Sector Canton Ticker symbol
ABB electronic and electrical equipment Zurich ABBN
Alcon healthcare Fribourg ALC
Credit Suisse banks Zurich CSGN
Geberit building materials and fixtures St. Gallen GEBN
Givaudan specialty chemicals Geneva GIVN
Holcim building materials and fixtures St. Gallen HOLN
Logitech International SA computer hardware and software Vaud LOGN
Lonza pharmaceuticals and biotechnology Basel LONN
Nestlé food products Vaud NESN
Novartis pharmaceuticals Basel NOVN
Partners Group private equity Zug PGHN
Richemont clothing and accessories Geneva CFR
Roche pharmaceuticals Basel ROG
SGS business support services Geneva SGSN
Sika specialty chemicals Zug SIKA
Swiss Life life insurance Zurich SLHN
Swiss Re reinsurance Zurich SREN
Swisscom fixed line telecommunications Bern SCMN
UBS banks Zurich UBSG
Zurich Insurance Group full line insurance Zurich ZURN

See also

Notes and references

  1. ^ a b "Launch of the SPI 20". SIX Swiss Exchange. Retrieved 12 April 2019.
  2. ^ a b c "Swiss Performance Index (SPI) Family – Factsheet" (PDF). SIX Swiss Exchange. Archived from the original (PDF) on 2019-04-12. Retrieved 12 April 2019.